Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy

Volume: 199, Issue: 6, Pages: 1452 - 1458
Published: Jun 1, 2018
Abstract
No AccessJournal of UrologyAdult Urology1 Jun 2018Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy Homayoun Zargar, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Trinity J. Bivalacqua, Philippe E. Spiess, Peter C. Black, Wassim Kassouf, and Collaborators Homayoun ZargarHomayoun Zargar Vancouver Prostate Centre, University of British Columbia, Vancouver,...
Paper Details
Title
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy
Published Date
Jun 1, 2018
Volume
199
Issue
6
Pages
1452 - 1458
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.